Bath & Body Works (NYSE:BBWI – Get Free Report) had its price target lowered by investment analysts at Morgan Stanley from $22.00 to $21.00 in a report issued on Friday, MarketBeat.com reports. The firm presently has an “equal weight” rating on the stock. Morgan Stanley‘s target price would suggest a potential upside of 12.48% from the stock’s current price.
BBWI has been the subject of a number of other research reports. Deutsche Bank set a $22.00 price objective on Bath & Body Works in a report on Thursday, August 27th. Barclays lowered their target price on shares of Bath & Body Works from $23.00 to $22.00 and set an “equal weight” rating for the company in a research note on Thursday, August 27th. Argus restated a “hold” rating on shares of Bath & Body Works in a report on Wednesday, September 16th. JPMorgan Chase & Co. raised their price target on shares of Bath & Body Works from $22.00 to $24.00 and gave the stock a “neutral” rating in a research note on Tuesday, August 18th. Finally, Jefferies Financial Group reiterated a “hold” rating and set a $21.00 price objective on shares of Bath & Body Works in a report on Thursday. Four research analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, Bath & Body Works presently has a consensus rating of “Hold” and an average price target of $22.00.
Get Our Latest Stock Report on Bath & Body Works
Bath & Body Works Trading Down 1.3%
Bath & Body Works (NYSE:BBWI – Get Free Report) last announced its quarterly earnings data on Thursday, November 19th. The company reported $0.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.12 by $0.14. Bath & Body Works had a net margin of 10.32% and a negative return on equity of 57.47%. The business had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.55 billion. During the same quarter last year, the firm earned $0.37 earnings per share. The firm’s quarterly revenue was down 1.1% compared to the same quarter last year. Bath & Body Works has set its Q4 2026 guidance at 1.410-1.610 EPS and its FY 2026 guidance at 2.600-2.800 EPS. Sell-side analysts forecast that Bath & Body Works will post 2.77 EPS for the current year.
Hedge Funds Weigh In On Bath & Body Works
A number of large investors have recently bought and sold shares of BBWI. Elevation Wealth Partners LLC boosted its position in Bath & Body Works by 5,278.8% during the 2nd quarter. Elevation Wealth Partners LLC now owns 1,775 shares of the company’s stock valued at $41,000 after acquiring an additional 1,742 shares in the last quarter. Parallel Advisors LLC lifted its stake in shares of Bath & Body Works by 35.5% during the 1st quarter. Parallel Advisors LLC now owns 2,570 shares of the company’s stock worth $48,000 after purchasing an additional 673 shares during the last quarter. United Southern Bank Trust Department purchased a new stake in shares of Bath & Body Works during the 3rd quarter worth $58,000. Meeder Asset Management Inc. bought a new stake in Bath & Body Works during the second quarter valued at about $66,000. Finally, Global Retirement Partners LLC bought a new stake in Bath & Body Works during the second quarter valued at about $71,000. Institutional investors own 95.14% of the company’s stock.
More Bath & Body Works News
Here’s some of the latest news about BBWI:
- Positive Sentiment: Third-quarter adjusted EPS of $0.26 topped the $0.12 consensus, while revenue of about $1.58 billion also exceeded estimates. Digital and wholesale gains helped offset weaker store performance. BBWI Q3 earnings beat estimates on digital and wholesale gains
- Neutral Sentiment: A limited-edition holiday fragrance collection with Pantone adds a product and gifting initiative, though its near-term financial impact is unclear. Bath & Body Works and Pantone holiday collection
- Negative Sentiment: Q4 EPS guidance of $1.41–$1.61 came in below the $1.72 analyst consensus, with revenue guidance also below expectations at the midpoint. Reports of softer expected holiday sales add to concerns about near-term demand. Bath & Body Works trims FY26 EPS outlook
About Bath & Body Works
Bath & Body Works, Inc. is a specialty retailer focused on personal care and home fragrance products. Its offerings include body lotions, soaps, fragrances, hand sanitizers, candles and other home-fragrance items, sold under the Bath & Body Works and White Barn brands. The company serves customers through its stores and e-commerce platform in the United States and Canada, as well as through international franchise, license and wholesale partners. Bath & Body Works traces its roots to a store launched in 1990.
Recommended Stories
- Five stocks we like better than Bath & Body Works
- ZIM Just Posted Huge Profits, But Its $35 Buyout Is Still in Limbo
- Owens Corning’s Stock Slump May Have a Silver Lining for Dividend Investors
- The Patchpocalypse Could Be a Big Opportunity for These 2 Cybersecurity Stocks
- Anthropic’s Record IPO Could Ease a Major Concern for Broadcom Investors
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.
